Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novotech
Biotech
Former Roche oncology head turns to Tubulis—Chutes & Ladders
Former Roche oncology head turns to Tubulis. Argenx CEO passes baton to operating chief. Longtime Charles River leader eyes retirement.
Darren Incorvaia
,
Zoey Becker
Jan 9, 2026 8:30am
Investment firms secure large stakes in CRO Novotech
Apr 2, 2025 2:00am
Holoclara wriggles into ph. 1, sets sights on immune disease
Dec 18, 2024 9:05am
Number of esophageal cancer trials rise with incidence rate
Jul 31, 2024 3:20pm
Europe leads in cystic fibrosis trials, North America for AML
Apr 16, 2024 5:00pm
Asia-Pacific CRO Novotech makes US play with NCGS acquisition
May 4, 2022 1:39pm